Fundraising FoxNotation Capital — 2022 Investments
5 investments dated 2022 · listed companies and verified rows first · show all
Cashmere provides a multi-signature Solana wallet that allows enterprises and startups to manage cryptocurrency holdings across multiple authorized signers rather than concentrating control in a single account.
Crypto & Web3FintechSan Francisco, US
Shashank Khanna(Founder)inRebecca Lee(Founder)inCharlotte McGinn(Founder)in
Co-investorsCanapi VenturesCoinbase VenturesFortitude VenturesSoma CapitalSouth QuadY Combinator+13 more
Housecat is an AI-powered email assistant that works inside the inbox to automate tasks such as updating the CRM, saving attachments, scheduling, drafting documents and spreadsheets, and running email workflows.
AI & Machine LearningFuture of WorkSaaS
Thomas George(Founder)in
Co-investorsBlueYard Capital
Wayfinder is an education platform sold to schools and school districts, offered through state and federal funding programs.
EdTechSaaS
Claudia Bicen(Founder)Patrick Cook-Deegan(Founder)
Co-investorsCollab+CurrencyDesigner FundOregon Venture FundSorenson Impact FoundationBattery VenturesBoxOne Ventures+8 more
.jpeg){kind=logo}
Wayfinder is a seed-stage venture capital fund that invests in early-stage founders building B2B companies across multiple industries including finance, enterprise software, AI, manufacturing, and robotics.
Advanced ManufacturingAI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsEnterprise SoftwareHardwareSpace Tech
Tom Feldman(CTO and Co-Founder)Andy Lapsa(CEO and Co-Founder)Ant Wilson(CTO and Co-Founder)Paul Copplestone(CEO and Co-Founder)Yuri Sagalov(Founder and Managing Partner)
Co-investorsElementum VenturesInvariantes FundBoxOne VenturesConscience VCDivergent CapitalGENESIS CONSORTIUM+3 more
Wayfinder develops RNA-targeting small molecule therapies using expertise in RNA biophysics, molecular biology, and machine learning to discover treatments for currently incurable diseases.
AI & Machine LearningBiotechDeep Tech
Jason Fontana(Founder & CEO)inDavid Sparkman-Yager(Founder & CTO)inChuhern Hwang(Founder & Head of Drug Discovery)in
Co-investorsDivergent CapitalSocial StartsSOSVBoxOne VenturesConscience VCEntrepreneur First+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.